Seagen announced closing of $1.0 billion stock sale to Merck
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
-
-
Fred Hutch completed move-in of Lake Union Steam Plant
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
-
University of Washington blood test detected past infections with new coronavirus
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
-
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
-
Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
-
Just – Evotec Biologics initiated construction of first JPOD Facility in North America
On Jan. 14, 2020, Evotec announced that the wholly-owned Seattle based company Just – Evotec Biologics had initiated…
-
Thomas J. Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research Center
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
-
PATH announced Nikolaj Gilbert as President and CEO
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
-
Pascal Biosciences commenced cannabinoid testing of human volunteers and patients
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
-
Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapse
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
-
Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
-
Celgene acquired Juno Therapeutics for $9 billion
On Jan. 22, 2018, Celgene and Juno Therapeutics announced the signing of a merger agreement in which Celgene…
-
Costco co-founder Jeff Brotman and Dan Baty donated $50 million to create the Brotman Baty Institute for Precision Medicine
On Dec. 6, 2017, Costco Founder Jeffrey and Susan Brotman and Pam and Dan Baty announced a $50…
-
Biotechnology | Environmental | Genomics | Life Science History | Medicine | Non-Profit Research | Pharmaceutical
Earth Microbiome Project scientists announced unprecedented catalog of microbial life on planet Earth
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
-
The Bill & Melinda Gates Foundation pledged $279 million to University of Washington’s Institute for Health Metrics and Evaluation
On Jan. 25, 2017, the Bill & Melinda Gates Foundation pledged $279 million to the University of Washington’s…
-
University of Washington Population Health Initiative received $210 million transformative gift from the Gates Foundation
On Oct. 25, 2016, the University of Washington’s Population Health Initiative received a $210 million gift from the…
-
Washington Life Science Evolution, 2015
Washington Life Science Evolution illustrates life science companies and non-profit research organizations located in the State of Washington…
-
Washington Life Science History
Washington Life Science History is a poster that illustrates significant events in the development of the life science…
-
Dendreon was acquired by Valeant Pharmaceuticals for $495 million
On Feb. 23, 2015, a bankruptcy judge approved the sale of the assets of Dendreon Corp., a Seattle-based…
-
Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
-
Philanthropist Paul G Allen founded the Allen Institute for Cell Science with $100 million
On Dec. 8, 2014, philanthropist and entrepreneur Paul G. Allen announced a commitment of $100 million to create…
-
OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…
-
Benaroya Research Institute received 7-year award to lead Immune Tolerance Network
On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason…
-
Juno Theraputics was founded
On Dec. 3, 2013, Juno Theraputics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, was…
-
The Roux Prize was established
On Nov. 9, 2013, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington launched…
-
Atossa Genetics completed its IPO
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
-
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
-
Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from Madigan Army Medical
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
-
Trubion Pharmaceutical was acquired by Emergent BioSolutions
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
-
William Hagopian was appointed Scientific Director at the Pacific Northwest Diabetes Research Institute
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
